Abstract
There is much evidence confirming the crucial role played by the gut microbiota in modulating the immune system in the onset of autoimmune diseases. In this article, we focus on the relationship between alterations in the microbiome and the onset of diabetes mellitus type 1 and LADA, in light of the latest evidence. We will then look at both how the role of the gut microbiota appears to be increasingly crucial in the pathogenesis of these disorders and how this aspect may be instrumental in the development of new potential therapeutic strategies that modulate the gut microbiota, such as probiotics, prebiotics, and fecal microbiota transplantation.
Lingua originale | English |
---|---|
pagine (da-a) | 707-N/A |
Rivista | Biomedicines |
Volume | 11 |
DOI | |
Stato di pubblicazione | Pubblicato - 2023 |
Keywords
- LADA
- type 1 diabetes mellitus
- gut microbiota